NCT02333890View on ClinicalTrials.gov

A Phase 2 Randomized, Double-blind Trial Evaluating the Effects of Chloroquine in Breast Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

March 31, 2018

Conditions
Breast CancerInvasive Breast Cancer
Interventions
DRUG

Chloroquine

chloroquine 500 mg daily as an oral capsule during the wait time to surgery.

DRUG

Placebo

Trial Locations (1)

Unknown

RECRUITING

The Ottawa Hospital Woman's Breast Health Centre, Ottawa

Sponsors
All Listed Sponsors
lead

Ottawa Hospital Research Institute

OTHER